{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:19:36Z","timestamp":1790720376606,"version":"4.1.0"},"reference-count":25,"publisher":"Society of Nuclear Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,4,8]]},"published-print":{"date-parts":[[2025,8]]},"DOI":"10.2967\/jnumed.125.269470","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T15:00:39Z","timestamp":1747926039000},"page":"1291-1298","source":"Crossref","is-referenced-by-count":8,"title":["Establishing In\u00a0Vitro Dosimetric Models and Dose\u2013Effect Relationships for <sup>177<\/sup>Lu-DOTATATE in Neuroendocrine Tumors"],"prefix":"10.2967","volume":"66","author":[{"given":"Giulia","family":"Tamborino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pleun","family":"Engbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tijmen H.","family":"de Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thom G.A.","family":"Reuvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Verhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Konijnenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Nonnekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"2025080106551268000_66.8.1291.1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2967\/jnumed.118.213496","article-title":"New developments in peptide receptor radionuclide therapy","volume":"60","author":"Nicolas","year":"2018","journal-title":"J Nucl Med."},{"key":"2025080106551268000_66.8.1291.2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.066"},{"key":"2025080106551268000_66.8.1291.3","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1200\/JCO.2018.78.5865","article-title":"Health-related quality of life in patients with progressive midgut neuroendocrine tumors treated with 177Lu-DOTATATE in the phase III NETTER-1 trial","volume":"36","author":"Strosberg","year":"2018","journal-title":"J Clin Oncol."},{"key":"2025080106551268000_66.8.1291.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607427"},{"key":"2025080106551268000_66.8.1291.5","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266991"},{"key":"2025080106551268000_66.8.1291.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265987"},{"key":"2025080106551268000_66.8.1291.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.267023"},{"key":"2025080106551268000_66.8.1291.8","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-019-01320-x"},{"key":"2025080106551268000_66.8.1291.9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0307332101"},{"key":"2025080106551268000_66.8.1291.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-9002(03)01368-8"},{"key":"2025080106551268000_66.8.1291.11","doi-asserted-by":"crossref","unstructured":"Shen X , Diamond S , Gu Y , Boyd S. Disciplined convex\u2013concave programming. Paper presented at: IEEE 55th Conference on Decision and Control; 2016, Las Vegas, NV:1009\u20131014.","DOI":"10.1109\/CDC.2016.7798400"},{"key":"2025080106551268000_66.8.1291.12","unstructured":"ESTAR: stopping power and range tables for electrons. National Institute of Standards and Technology Physical Measurement Laboratory website. https:\/\/physics.nist.gov\/PhysRefData\/Star\/Text\/ESTAR.html. Accessed April 22, 2025."},{"key":"2025080106551268000_66.8.1291.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.056036"},{"key":"2025080106551268000_66.8.1291.14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00259-022-05934-2","article-title":"An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine","volume":"50","author":"Pouget","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025080106551268000_66.8.1291.15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40658-020-0276-5","article-title":"Cellular dosimetry of [177Lu]Lu-DOTA-[Tyr3]octreotate radionuclide therapy: the impact of modeling assumptions on the correlation with in\u00a0vitro cytotoxicity","volume":"7","author":"Tamborino","year":"2020","journal-title":"EJNMMI Phys."},{"key":"2025080106551268000_66.8.1291.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.131037"},{"key":"2025080106551268000_66.8.1291.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.175695"},{"key":"2025080106551268000_66.8.1291.18","doi-asserted-by":"publisher","DOI":"10.1118\/1.3070587"},{"key":"2025080106551268000_66.8.1291.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262122"},{"key":"2025080106551268000_66.8.1291.20","doi-asserted-by":"crossref","first-page":"135018","DOI":"10.1088\/1361-6560\/ab23c4","article-title":"Radiosensitivity of colorectal cancer to 90Y and the radiobiological implications for radioembolisation therapy","volume":"64","author":"Lee","year":"2019","journal-title":"Phys Med Biol."},{"key":"2025080106551268000_66.8.1291.21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000338793","article-title":"The role of cell lines in the study of neuroendocrine tumors","volume":"96","author":"Grozinsky-Glasberg","year":"2012","journal-title":"Neuroendocrinology."},{"key":"2025080106551268000_66.8.1291.22","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1016\/j.ijrobp.2011.12.068","article-title":"Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy","volume":"83","author":"Arvold","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2025080106551268000_66.8.1291.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2008.12.044"},{"key":"2025080106551268000_66.8.1291.24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3390\/cancers14010235","article-title":"Hyperfractionated treatment with 177Lu-octreotate increases tumor response in human small-intestine neuroendocrine GOT1 tumor model","volume":"14","author":"Elvborn","year":"2022","journal-title":"Cancers (Basel)."},{"key":"2025080106551268000_66.8.1291.25","doi-asserted-by":"crossref","unstructured":"Ryhiner M Song Y Hong J . A mathematical model for the investigation of combined treatment of radiopharmaceutical therapy and PARP inhibitors. Eur J Nucl Med Mol Imaging. February 20, 2025 [Epub ahead of print].","DOI":"10.1007\/s00259-025-07144-y"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.269470","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T13:55:33Z","timestamp":1754056533000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.269470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,1]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.2967\/jnumed.125.269470"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.269470","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]}}}